» Articles » PMID: 26341565

The Role of Blood Rheology in Sickle Cell Disease

Overview
Journal Blood Rev
Publisher Elsevier
Specialty Hematology
Date 2015 Sep 6
PMID 26341565
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

Studies performed in the last decades have highlighted the need to better understand the contribution of the endothelium, vascular function, oxidative stress, inflammation, coagulation, hemolysis and vascular adhesion mechanisms to the pathophysiology of acute vaso-occlusive like events and chronic organ damages in sickle cell disease (SCD). Although SCD is a hemorheological disease, a few works focused on the contribution of blood viscosity, plasma viscosity, red blood cell deformability and aggregation in the pathophysiology of SCD. After a brief description of basic hemorheology, the present review focuses on the role of the hemorheological abnormalities in the causation of several SCD complications, mainly in sickle cell anemia and hemoglobin (Hb) SC disease. Several genetic and cellular modulators of blood rheology in SCD are discussed, as well as unresolved questions and perspectives.

Citing Articles

Friction in soft biological systems and surface self-organization: the role of viscoelasticity.

Pajic-Lijakovic I, Milivojevic M, McClintock P Biophys Rev. 2025; 16(6):813-829.

PMID: 39830128 PMC: 11735778. DOI: 10.1007/s12551-024-01248-9.


Computational Analysis of Flow and Transport Suggests Reduced Oxygen Levels Within Intracranial Aneurysms, Especially in Individuals With Sickle-Cell Disease.

Bazzi M, Wiputra H, Wood D, Barocas V J Biomech Eng. 2024; 147(2.

PMID: 39636010 PMC: 11748962. DOI: 10.1115/1.4067323.


Gene-environmental influence of space and microgravity on red blood cells with sickle cell disease.

Igbineweka N, van Loon J NPJ Genom Med. 2024; 9(1):44.

PMID: 39349487 PMC: 11442622. DOI: 10.1038/s41525-024-00427-7.


A Compact Differential Dynamic Microscopy-based Device (cDDM): An Approach Tool for Early Detection of Hypercoagulable State in Transfusion-Dependent-β-Thalassemia Patients.

Petiwathayakorn T, Paradee N, Hantrakool S, Jarujareet U, Intharah T, Srichairatanakool S ACS Appl Bio Mater. 2024; 7(7):4710-4724.

PMID: 38920024 PMC: 11253095. DOI: 10.1021/acsabm.4c00516.


The Application of Fluorescence Anisotropy for Viscosity Measurements of Small Volume Biological Analytes.

Sydor M, Serban M J Exp Theor Anal. 2024; 1(2):86-96.

PMID: 38633433 PMC: 11022525. DOI: 10.3390/jeta1020007.


References
1.
Guasch A, Zayas C, Eckman J, Muralidharan K, Zhang W, Elsas L . Evidence that microdeletions in the alpha globin gene protect against the development of sickle cell glomerulopathy in humans. J Am Soc Nephrol. 1999; 10(5):1014-9. DOI: 10.1681/ASN.V1051014. View

2.
Aslan M, Freeman B . Reactive species in sickle cell disease. Ann N Y Acad Sci. 2000; 899:375-91. DOI: 10.1111/j.1749-6632.2000.tb06201.x. View

3.
Klings E, Farber H . Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease. Respir Res. 2001; 2(5):280-5. PMC: 59517. DOI: 10.1186/rr70. View

4.
Rosse W, Narla M, Petz L, Steinberg M . New Views of Sickle Cell Disease Pathophysiology and Treatment. Hematology Am Soc Hematol Educ Program. 2001; :2-17. DOI: 10.1182/asheducation-2000.1.2. View

5.
Reiter C, Wang X, Tanus-Santos J, Hogg N, Cannon 3rd R, Schechter A . Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 2002; 8(12):1383-9. DOI: 10.1038/nm1202-799. View